Table 1 Baseline characteristics of the study sample.
| Â | No fascial suturing (n = 77) | Fascial suturing (n = 77) |
|---|---|---|
Age | 61.1 (57.8, 64.1) | 61.3 (57.7, 65.3) |
PSA at diagnosis | 5.19 (3.66, 6.59) | 5.17 (3.76, 6.59) |
Clinical stage T1 | 57 (74%) | 52 (68%) |
Clinical stage T2a | 12 (16%) | 14 (18%) |
Clinical stage T2b+ | 8 (10%) | 11 (14%) |
Biopsy Gleason grade | Â | Â |
6 | 28 (36%) | 29 (38%) |
7 | 42 (55%) | 40 (52%) |
8 | 7 (9%) | 8 (10%) |
Patients undergoing surgery | n = 74 | n = 77 |
Pathologic Gleason grade1 | Â | Â |
6 | 10 (14%) | 8 (11%) |
7 | 57 (77%) | 59 (79%) |
8 | 7 (9%) | 8 (11%) |
Positive surgical margins2 | 11 (15%) | 9 (12%) |
Seminal vesicle invasion | 5 (7%) | 7 (9%) |
Extraprostatic extension | 35 (47%) | 36 (48%) |
Lymph node invasion | 6 (8%) | 6 (8%) |
| Â | Irrigation (n = 77) | No irrigation (n = 77) |
Age | 60.3 (55.9, 65.2) | 59.9 (56.1, 64.2) |
PSA at diagnosis | 4.95 (3.72, 6.90) | 4.95 (3.66, 6.90) |
Clinical stage T1 | 44 (57%) | 49 (64%) |
Clinical stage T2a | 18 (23%) | 16 (21%) |
Clinical stage T2b+ | 15 (19%) | 12 (16%) |
Biopsy Gleason grade | Â | Â |
6 | 30 (39%) | 29 (38%) |
7 | 32 (42%) | 34 (44%) |
8 | 15 (19%) | 14 (18%) |
Patients undergoing surgery | n = 74 | n = 76 |
Pathologic Gleason grade1 | Â | Â |
6 | 9 (12%) | 11 (15%) |
7 | 59 (78%) | 57 (76%) |
8 | 8 (11%) | 7 (9%) |
Positive surgical margins2 | 11 (14%) | 13 (17%) |
Seminal vesicle invasion | 10 (13%) | 8 (11%) |
Extraprostatic extension | 35 (45%) | 34 (45%) |
Lymph node invasion | 7 (9%) | 7 (9%) |